Nonacus Limited investment portfolio

Advanced Genomics Limited develops and supplies genetic‑testing solutions for scientific and clinical customers, including partners across the United Kingdom and the Asia‑Pacific region. It also invests in biotech ventures, such as funding a liquid‑biopsy test for monitoring cancer in dogs.

CanSense offers a non‑invasive blood test that uses laser spectroscopy and artificial‑intelligence analysis to detect bowel cancer at an early stage, aiming to reduce the need for colonoscopies and improve patient outcomes. The product targets clinicians, healthcare providers and patients seeking a fast, cost‑effective screening tool for colorectal cancer.